R84646, and Rs1008805 Polymorphism in CYP19 and Breast Cancer Susceptibility in Zhejiang Popu-Lation
邵喜英,许涌,苏丹,许凯声,冯建国,牟翰舟,徐笑红,陈占红,王晓稼
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2009.04.009
2009-01-01
Abstract:Objective To investigate the effect of rs4646, and rs1008805 polymorphism in CYP19 gone on genetic susceptibility for breast cancer in Zhejiang population. Methods 233 breast canc-er patients and 180 healthy controls were involved in the study. Genotype analysis was performed through TaqMan assay. The odd ratios (OR) and 95% confidence intervals (CI) were calculated by unconditional Logistic regression model. Results (1) The frequency of CC, AC, and AA genotype of rs4646 in case group and controls was 47.6%, 41.6%, 10.7% and 52.8% ,38.3%, 8.9%, respectively. The frequency of C,and A allele in case group and controls were 68.5%, 31.5% and 71.9%, 28.1%, respectively. No significant association was found between rs4646 polymorphism and breast cancer susceptibility. (2) The frequency of AA,AG,GG genotype of rs1008805 in case group and controls was 44.6%, 43.3%,12.0% and 51.4%, 40.2%, 8.4%, respectively. The frequency of A, and G allele in case group and controls was 66.3%, 33.7% and 71.5%, 28.5%, respectively. No significant association was found between rs1008805 polymorphism and breast cancer susceptibility. (3) No significant association was found be-tween rs4646, and rs1008805 polymorphism and pathological features. Conclusion There may be no rela-tionship between rs646,and rs1008805 polymorphism in CYPI9 gone and breast cancer susceptibility in Zhejiang population. Rs4646, and rs1008805 polymorphism in CYP19 may not be promising candidate lo-cus for breast cancer susceptibility in clinical genetic test.